99 Pharmacist-physician collaborative care model vs. standard care: Assessing time to blood pressure goal

Thursday, May 19, 2016
Eric Parod, PharmD1, Dave Dixon, PharmD, BCPS, CDE, CLS, AACC, FNLA2, Evan Sisson, Pharm.D., M.H.A.3, Pramit Nadpara, PhD4, Dr. Leticia R. Moczygemba, PharmD, PhD5, Dan Carl, MD6 and Alan Dow, MD6
1School of Pharmacy, Virginia Commonwealth University, Richmond, VA
2Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA
3Department of Pharmacotherapy and Outcome Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA
4Virginia Commonwealth University School of Pharmacy, Richmond, VA
5Department of Pharmacotherapy and Outcomes Sciences, Virginia Commonwealth University School of Pharmacy, Richmond, VA
6VCU Health System, Richmond, VA
Introduction: Pharmacist-­physician collaborative care models (PCCMs) are shown to improve BP control rates and reduce mean BP, but it is unknown if PCCMs affect time to BP goal.

Objectives: The primary objective is to compare the time to BP control of a PCCM to standard care (SC) in an indigent population. Secondary objectives include the proportion of patients with BP control at the end of the 12-month follow-up period and any factors that may affect time to BP control.

Study Design: This retrospective cohort study utilizes paper and electronic medical records.

Methods: New patients first seen in clinic between January 1, 2012 and December 31, 2013 with a documented diagnosis of hypertension (or taking antihypertensive medication at the initial visit) were included. Exclusion criteria consists of eGFR <30ml/min, <2 BP readings, and pregnancy. A Virginia safety-net free clinic serves as the PCCM site and a Virginia health system providing primary care to patient-assistance program recipients serves as the SC site. Time to BP control is defined as the time from the initial clinic visit to the first visit with a BP <140/90. The proportion of patients at goal was determined by evaluating the last BP measurement obtained during the 12-month follow-up period. The median (IQR) time to goal for each group was calculated and descriptive statistics used for patient demographics.

Results: Interim results for the 350 eligible PCCM patients show the median time to BP control was 21 days (IQR 15-28) requiring a mean of 2.6 visits. At 12-months, 61% of PCCM patients were at goal. The remaining data collection and analysis for the SC group is expected to be complete by April 2016.

Conclusions: These preliminary findings suggest that the early and intensive follow-up provided by the PCCM quickly gets patients with hypertension to their goal BP.